AMRN · Amarin Corp ADR
United States · RS rating 13 · As of 2026-10-14
| Price | 11.61 USD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 14 / 21 / 18 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 14 / 44 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +100.0% |
| Sales growth Q/Q | -0.9% |
| Distance from 52-week high | +42.7% |
| Market cap (USD) | $306.0M |